PTC Therapeutics is seeking participants for its MIT-E Study, looking at whether an investigational drug (PTC-743 also known as EPI-743) can reduce the number of seizures in children and teens who have mitochondrial disease with associated Epilepsy.  

Participants must:

- Be under 18 years old;

- Have inherited mitochondrial disease with associated Epilepsy and symptoms that have been ongoing for at least six months; and

- Have had at least six seizures in the last four weeks.  

Learn more here.